C12N 2770/32123
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2770/32123 (Virus like particles [vlp]) appears on 26 US grants and 34 published applications in this corpus.
Search patents in C12N- Granted patents
- 26
- Published applications
- 34
- Assignees
- 24
- Inventors
- 82
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 0 |
| 2016 | 2 | 2 |
| 2017 | 0 | 2 |
| 2018 | 3 | 5 |
| 2019 | 5 | 7 |
| 2020 | 6 | 0 |
| 2021 | 3 | 2 |
| 2022 | 0 | 3 |
| 2023 | 0 | 1 |
| 2024 | 1 | 5 |
| 2025 | 2 | 0 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Foot-and-mouth disease virus-like particle antigen, vaccine composition, preparation method, and use thereof28 Apr 2026US 12,611,452 B2Pulike Biological Engineering, Inc.
- Engineered Hansenula fungi efficiently expressing CA10 virus-like particles and uses thereof18 Mar 2025US 12,251,435 B2Beijing Minhai Biotechnology Co., Ltd.
- Foot-and-mouth disease virus-like particle antigen, and vaccine composition, preparation method, and application thereof18 Feb 2025US 12,226,472 B2Pulike Biological Engineering, Inc.
- Recombinant virus capable of stably expressing target proteins20 Feb 2024US 11,904,010 B2Boehringer Ingelheim Vetmedica (China) Co., Ltd.
- Method of purifying virus-like-particles7 Dec 2021US 11,191,824 B1The Government of the United States of America, as represented by the Secretary of Homeland Security
- Recombinant protein comprising protein derived from foot-and-mouth disease virus type o capsid protein and sfc protein and use thereof28 May 2026US 2026/0146065 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
- Method of producing a foot and mouth disease virus virus-like particle21 Nov 2024US 2024/0382579 A1Intervet Inc.
- Fmdv virus-like particle with double stabilizing mutation14 Nov 2024US 2024/0374706 A1The Pirbright Institute
- Method of producing a foot and mouth disease virus virus-like particle31 Oct 2024US 2024/0358815 A1Intervet Inc.
- Fmdv virus-like particle with stabilizing mutation31 Oct 2024US 2024/0358816 A1Intervet Inc.
Most cited
By later US patents
- Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof6US 10,385,319 B2The Governement of the United States of America, as represented by the Secretary of Homeland Security · 2019
- Leader-proteinase deleted foot-and-mouth disease viruses and their use as vaccines5US 5,824,316 AThe United States of America as represented by the Secretary of Agriculture · 1998
- Methods of making and using vaccines utilizing minicircle DNA expression vectors for production of foot-and-mouth-disease virus proteins and virus-like particles4US 9,975,926 B2The United States of America, as represented by the Secretary of Homeland Security · 2018
- Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease3US 10,308,927 B2The United States of America, as represented by the Secretary of Homeland Security · 2019
- Modified foot and mouth disease virus (FMDV) VP1 capsid protein3US 9,457,075 B2The Pirbright Institute · 2016